British Orthopaedic Research Society Annual Meeting 2026

📅 8–9th September 2026
📍 Technology & Innovation Centre, University of Strathclyde, Glasgow, United Kingdom

BORS 2026 Provisional Programme Now Available

The meeting will feature five themed scientific sessions, invited keynote lectures, the BORS Presidential Lecture, rapid poster presentations, the BORS–BJR Travelling Fellowship update, and a MAINSTREAM-sponsored session on orthopaedic cell therapies.

BORS_2026_Programme_v2 Download

Registration remains open until 31st August 2026. Presenting authors should register by 14th August 2026 to confirm their place in the scientific programme.

Join us for the BORS Bash – Tuesday 8th September, from 7 pm.
Add a £60 ticket during registration for our conference dinner and social at Strathclyde Students’ Union. The evening includes a three-course meal, a welcome drink and half a bottle of wine, with exclusive use of the bar, pool tables and darts.

Register for BORS 2026

Up to 11 CPD points awarded by the Royal College of Surgeons of England.

Keynote Speakers

We are delighted to welcome five keynote speakers to BORS 2026, bringing expertise from across orthopaedic surgery, musculoskeletal imaging, biomechanics, infection and translational research.

Professor Neal Millar

Translational Orthopaedics … Are We There Yet??

Professor Neal Millar is Professor of Orthopaedics at the University of Glasgow and an academic shoulder surgeon at the Queen Elizabeth University Hospital in Glasgow. He leads a basic science laboratory investigating the molecular pathophysiology of tendinopathy and is internationally recognised for his work in tendon disorders. His specialist interests include rotator cuff problems, shoulder instability, arthritis, stiffness and complex tendinopathy.

Dr Jenny Gregory

Shape Matters in Orthopaedics: Understanding Osteoarthritis Risk and Outcomes

Dr Jenny Gregory is a Senior Lecturer in the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen. Her research applies advanced medical image analysis to musculoskeletal health, disease and ageing, with particular expertise in bone morphology, osteoarthritis and physical activity. She is internationally recognised for her work in statistical shape modelling and its application to understanding clinically relevant patterns of musculoskeletal disease.

Mr Akash Sharma

Robotic TKA: Evolution or Revolution?

Mr Akash Sharma is a Consultant Knee Surgeon at the Royal Orthopaedic Hospital, Birmingham, and President of CAOS UK. He specialises in robotic-assisted knee replacement, partial knee replacement, ligament reconstruction and complex revision surgery. His work focuses on precision surgery, digital innovation and improving patient outcomes through computer-assisted techniques, alongside advancing education and the safe adoption of emerging orthopaedic technologies.

Professor Gordon Ramage

Biofilms at the Interface: Understanding and Tackling Infection in Orthopaedic Implants

Professor Gordon Ramage is Professor of Infection Prevention and Control and Director of the Research Centre for Health at Glasgow Caledonian University. An internationally recognised microbiologist, he has spent more than 30 years investigating microbial biofilms and their role in infection. His research spans bacterial and fungal biofilms, antimicrobial resistance, infection prevention, diagnostics and therapeutics, including biofilm-associated infections affecting medical devices and biomaterials.

Professor Chloe Scott

Clinical Confidence from Biomechanical Modelling

Professor Chloe Scott is a consultant hip, knee and trauma surgeon at the Royal Infirmary of Edinburgh and Editor-in-Chief of Bone & Joint Research. Her specialist clinical interests include complex knee arthroplasty and periprosthetic fracture management. Her research spans arthroplasty outcomes, robotic surgery, finite element analysis and knee biomechanics, and she is also an Honorary Professor of Mechanical Engineering at Imperial College London.

Orthopaedic Cell Therapies: From GMP Manufacturing to NHS Delivery

Wednesday 9 September | 11:50–13:05 | Sponsored by MAINSTREAM

A special BORS 2026 session exploring what it takes to translate advanced cell therapies from development towards clinical delivery.

Three invited speakers will examine the pathway from complementary perspectives: GMP manufacturing and process translation, health economics and market access, and the practical delivery of cellular therapies within the NHS. The presentations will be followed by a panel discussion and audience Q&A.

Dr Diana Martínez Redondo

Navigating GMP Manufacturing in Advanced Cell Therapy Development

Senior Scientist, Process Development and GMP Translation, Histocell S.L. CDMO

Dr Diana Martínez Redondo will explore the role of GMP manufacturing in the development of advanced cell therapies, including the core GMP concepts, operational considerations and quality systems required to support production of clinical-grade cell therapy products within a CDMO framework.

Thomas Strakosch

Value by Design in Advanced Therapy Development

Health Economics and Market Access Lead, Cell and Gene Therapy Catapult

Thomas Strakosch specialises in market access strategy, health technology appraisal decision-making and economic modelling for Advanced Therapy Medicinal Products. His presentation will explore how market access considerations can be incorporated into therapy development from an early stage to optimise the chances of commercial success, including an orthopaedic cell therapy health technology assessment exemplar.

Dr Samantha Carmichael MRCPharm

From Vein to Vein: The NHS Cellular Therapy Pathway

Lead Pharmacist, Clinical Trials, Research & Innovation and Advanced Therapy Medicinal Products, NHS Greater Glasgow & Clyde

Dr Samantha Carmichael has extensive experience supporting the development, regulatory oversight and delivery of cell and gene therapies, including first-in-human gene therapy studies, commercial and academic ATMP clinical trials, and licensed cellular therapies. She is actively involved in national ATMP networks supporting the adoption and expansion of innovative cellular and gene therapies across Scotland.

Panel Discussion and Audience Q&A

Following the three presentations, the speakers will come together for a 30-minute panel discussion and audience Q&A, considering the challenges involved in moving orthopaedic cell therapies from scientific development through manufacture, evaluation and ultimately clinical delivery.

Session sponsored by MAINSTREAM – UK Hub for Scale-up of Cell Manufacturing

About BORS 2026

The British Orthopaedic Research Society (BORS) Annual Meeting 2026 will take place on 8–9th September 2026 at the Technology & Innovation Centre, University of Strathclyde, in the heart of Glasgow.

This year’s theme is Translational Orthopaedic Research, with a scientific programme spanning the breadth of musculoskeletal research—from fundamental discovery and bioengineering to clinical application.

BORS 2026 will be a pan-Glasgow meeting, organised by a cross-institutional committee representing:

University of Strathclyde
University of Glasgow
Glasgow Caledonian University
NHS Golden Jubilee
The Queen Elizabeth University Hospital

Each institution will lead a dedicated scientific session, highlighting the breadth of musculoskeletal and orthopaedic research taking place across the region.

The BORS Annual Meeting traditionally attracts a balanced audience of practising orthopaedic surgeons and academic researchers, creating a highly translational environment that fosters collaboration between clinicians, scientists, engineers, and industry partners.

CPD Points

The Royal College of Surgeons of England has awarded up to 11 CPD points.

Key Dates

Abstract notifications have now been sent to submitting authors. Presenting authors must register for the conference by 14th August 2026 to confirm their inclusion in the scientific programme. Presenting authors wishing to benefit from the early-bird rate should register by 1st August 2026.

The theme of this year’s meeting is Translational Orthopaedic Research, and the scientific programme will span the full breadth of musculoskeletal research, from fundamental science to clinical application.

Registration

Registration is now open.

Key registration dates

9th June 2026 – Registration opens
1st August 2026 – Early-bird registration closes
14th August 2026 – Presenting-author registration deadline
31st August 2026 – Registration closes

Early bird registration rates:

£250 – BORS Members
£300 – Non-members

Standard registration rates, applicable after the early-bird deadline (from 2nd August until Sunday, August 31st 2026):

£325 – BORS Members
£375 – Non-members

Conference

8–9th September 2026

BORS 2026 Annual Meeting
Technology & Innovation Centre
📍99 George Street, Glasgow, Scotland, G1 1RD (map)
University of Strathclyde, Glasgow

Accommodation

Delegates are encouraged to book accommodation in Glasgow as early as possible. Please note that another large conference, expected to attract approximately 8,000 delegates, is taking place in the city at the same time as BORS 2026, so hotel availability is likely to reduce quickly.

The Glasgow Convention Bureau has provided a list of recommended hotels close to the Technology & Innovation Centre, University of Strathclyde. This document also includes a direct link to Glasgow’s Booking.com page.

Accommodation Sheet TIC_May2026 Download

Delegates are responsible for arranging their own accommodation. Further information may be added to this page as it becomes available.

Venue

The Technology & Innovation Centre is one of the UK’s leading facilities for collaboration between academia, industry, and healthcare. The building provides modern lecture theatres, exhibition spaces, and networking areas, making it an ideal venue for scientific exchange and industry engagement.

Situated in the heart of Glasgow’s city centre innovation district, the venue is within walking distance of Glasgow Queen Street and Glasgow Central railway stations, as well as a wide range of hotels, restaurants, and cultural attractions. You can reach the venue using a range of transport options. Follow the link below for further information:

Travelling to the Technology & Innovation Centre (link)

Further information on the scientific programme, keynote speakers, abstract submission, and registration will be announced soon.

Awards

BORS offers a number of awards at the Annual Meeting to recognise excellence in orthopaedic and musculoskeletal research. If you are eligible and wish to be considered, please complete the relevant eligibility form and upload it during submission.

New Investigator Award
BORS offers a New Investigator Award at the Annual Meeting for the best podium presentation delivered by an eligible new investigator.
If you are eligible and would like to be considered for this award, please download the eligibility form from the BORS website and upload the completed form below.

confirmation_of_eligibility_form_bors2026 Download

Andrew Sprowson Award for Translational Research
Award for best podium presentation detailing translational research. Please state if you would like to be considered for this award. Note: BORS membership at the time of applying and during the annual meeting is an eligibility requirement.

Best Poster Presentation Award
This award is presented for the best poster presentation at the BORS Annual Meeting.
All submitted abstracts selected for poster presentation will automatically be considered.
No additional application or eligibility form is required.

Sponsorship and Exhibition Opportunities

BORS 2026 provides an excellent opportunity for organisations working in orthopaedics, musculoskeletal research, medical technology and related fields to engage with a highly translational audience of clinicians, researchers and industry partners.

A range of sponsorship and exhibition opportunities are available for organisations wishing to support the meeting.

For further information, please contact the Local Organising Committee: bors2026-conf@strath.ac.uk

Local Organising Committee